Shweta Chakrabarti, MSc
Jr. scientist – Omics
Shweta works as a Scientist at Rhenix. Currently, she is working on a Digital Medicine project exploring clinical applications of wearable devices in monitoring the health status of cancer patients and healthy volunteers.
Shweta has completed a Master’s degree in Bioinformatics from the Manipal Academy of Higher Education. Before joining Rhenix, Shweta worked with companies like CubeBio AI, Shodhaka life sciences, the Indian Institute of Technology, Madras, and Medall.
Rhenix has allowed her to gain scientific and research experience that leads to scientific publications.
Summary "Multifunctional silica-coated mixed polymeric micelles for integrin-targeted therapy of pediatric patient-derived Glioblastoma."
Glioblastoma (GBM) is the malignant brain tumor of the primary central nervous system (CNS) arising from the glial cells having an incidence ranging from 5 to 8 persons per 100,000 individuals...
Targeted therapeutics on Glioblastoma Multiforme | CellTalk
Glioblastoma (GBM) is the malignant brain tumor of the primary central nervous system arising from the glial cells having an incidence ranging from 5 to 8 persons per 100,000 people. The median survival duration is around 12 to 18 months with the...